Kirkland & Ellis advised Sheridan Capital Partners (“Sheridan”) on the closing of its oversubscribed third buyout fund, Sheridan Capital Partners Fund III, LP and its parallel fund, at $575 million in aggregate commitments, exceeding its target of $450 million. Sheridan is focused on making investments in lower middle market companies in recession resistant, non-discretionary markets within the healthcare industry. Read Sheridan’s press release The Kirkland team was led by investment funds partners Patrick Valenti, Kevin Wessel and Jeffrey Kaplan and associate Collin Maenhout; and included investment funds regulatory partner Christopher Scully and associate Tim Nolan; and tax partners Chris Odell and Dan Meehan and associate Liz Ji.